Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Beijing Tong Ren Tang Chinese Medicine Co Ltd banner
B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
OTC:BJTRF

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
OTC:BJTRF
Watchlist
Price: 0.6484 USD Market Closed
Market Cap: $1B
Write Note Create Alert Ask AI

Wall St Price Targets

BJTRF Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd

Wall Street analysts forecast BJTRF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BJTRF is 1.0601 USD with a low forecast of 1.0241 USD and a high forecast of 1.1178 USD.

BJTRF Lowest Forecast
Wall Street Target
$1.0241
58% Upside
BJTRF Average Forecast
Wall Street Target
$1.0601
63% Upside
BJTRF Highest Forecast
Wall Street Target
$1.1178
72% Upside
Lowest Forecast
Price Target
1.0241 USD
58% Upside
Average Forecast
Price Target
1.0601 USD
63% Upside
Highest Forecast
Price Target
1.1178 USD
72% Upside
Beijing Tong Ren Tang Chinese Medicine Co Ltd Competitors:
Price Targets
SUDEEPPHRM
Sudeep Pharma Ltd
-39% Downside
SUDEEPPHRM
Sudeep Pharma Ltd
-39% Downside

Revenue
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

11% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
11% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 1 year is 34%.

What are analyst estimates?

Operating Income
Forecast

12% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Pre-Tax Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Net Income
Forecast

7% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Continue BJTRF Research

Summary
BJTRF intrinsic value, competitors valuation, and company profile.
DCF Valuation
BJTRF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BJTRF stock valuation using valuation multiples.
Wall St Estimates
BJTRF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BJTRF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Beijing Tong Ren Tang Chinese Medicine Co Ltd listings:
HKEX • HKD
3613
 F • EUR
TQR
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BJTRF's stock price target?
Price Target
1.0601 USD

According to Wall Street analysts, the average 1-year price target for BJTRF is 1.0601 USD with a low forecast of 1.0241 USD and a high forecast of 1.1178 USD.

What is the Revenue forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
34%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 1 year is 34%.

What is the Operating Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.

What is the Pre-Tax Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join 354,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett